skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: Nome da Publicação: Journal Of Clinical Oncology remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Late toxicity and quality of life in oral cavity and oropharyngeal cancer survivors treated with chemoradiotherapy
Late toxicity and quality of life in oral cavity and oropharyngeal cancer survivors treated with chemoradiotherapy
Material Type:
Artigo 		Adicionar ao Meu Espaço

Late toxicity and quality of life in oral cavity and oropharyngeal cancer survivors treated with chemoradiotherapy

Oliveira, M. ; Luís, A. ; Carvalho, E. ; Esteves, S. ; Sargento, I. ; Ferreira, M. ; Moreira, A. ; Oliveira, J.

Journal of clinical oncology, 2010-05, Vol.28 (15_suppl), p.9092-9092 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
2
Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial
Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Tivozanib Versus Sorafenib As Initial Targeted Therapy for Patients With Metastatic Renal Cell Carcinoma: Results From a Phase III Trial

MOTZER, Robert J ; NOSOV, Dmitry ; KOGAN, Mikhail ; ALEKSEEV, Boris Y ; STERNBERG, Cora N ; SZCZYLIK, Cezary ; CELLA, David ; IVANESCU, Cristina ; KRIVOSHIK, Andrew ; STRAHS, Andrew ; ESTEVES, Brooke ; BERKENBLIT, Anna ; EISEN, Timothy ; HUTSON, Thomas E ; BONDARENKO, Igor ; LESOVOY, Vladimir ; LIPATOV, Oleg ; TOMCZAK, Piotr ; LYULKO, Oleksiy ; ALYASOVA, Anna ; HARZA, Mihai

Journal of clinical oncology, 2013-10, Vol.31 (30), p.3791-3799 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
3
Concomitant Cisplatin Plus Radiotherapy and High–Dose-Rate Brachytherapy Versus Radiotherapy Alone for Stage IIIB Epidermoid Cervical Cancer: A Randomized Controlled Trial
Concomitant Cisplatin Plus Radiotherapy and High–Dose-Rate Brachytherapy Versus Radiotherapy Alone for Stage IIIB Epidermoid Cervical Cancer: A Randomized Controlled Trial
Material Type:
Artigo 		Adicionar ao Meu Espaço

Concomitant Cisplatin Plus Radiotherapy and High–Dose-Rate Brachytherapy Versus Radiotherapy Alone for Stage IIIB Epidermoid Cervical Cancer: A Randomized Controlled Trial

ZULIANI, Antonio Carlos ; BARROS ESTEVES, Sergio Carlos ; TEIXEIRA, Luiz Carlos ; TEIXEIRA, Júlio César ; DE SOUZA, Gustavo Antonio ; SARIAN, Luis Otávio

Journal of clinical oncology, 2014-02, Vol.32 (6), p.542-547 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
4
Leptomeningeal carcinomatosis: Retrospective review of a large series
Leptomeningeal carcinomatosis: Retrospective review of a large series
Material Type:
Artigo 		Adicionar ao Meu Espaço

Leptomeningeal carcinomatosis: Retrospective review of a large series

Boavida Ferreira, João ; Garcez, Daniela ; Guimarães, António ; André, Saudade ; Esteves, Susana

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.e14005-e14005 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
5
Antitumor Activity and Safety of Tivozanib (AV-951) in a Phase II Randomized Discontinuation Trial in Patients With Renal Cell Carcinoma
Antitumor Activity and Safety of Tivozanib (AV-951) in a Phase II Randomized Discontinuation Trial in Patients With Renal Cell Carcinoma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Antitumor Activity and Safety of Tivozanib (AV-951) in a Phase II Randomized Discontinuation Trial in Patients With Renal Cell Carcinoma

NOSOV, Dmitry A ; ESTEVES, Brooke ; LIPATOV, Oleg N ; LYULKO, Alexei A ; ANISCHENKO, A. A ; CHACKO, Raju T ; DOVAL, Dinesh C ; STRAHS, Andrew ; SLICHENMYER, William J ; BHARGAVA, Pankaj

Journal of clinical oncology, 2012-05, Vol.30 (14), p.1678-1685 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
6
MIRASOL (GOG 3045/ENGOT OV-55): A randomized, open-label, phase III study of mirvetuximab soravtansine versus investigator’s choice of chemotherapy in advanced high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancers with high folate-alpha (FRα) expression
MIRASOL (GOG 3045/ENGOT OV-55): A randomized, open-label, phase III study of mirvetuximab soravtansine versus investigator’s choice of chemotherapy in advanced high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancers with high folate-alpha (FRα) expression
Material Type:
Artigo 		Adicionar ao Meu Espaço

MIRASOL (GOG 3045/ENGOT OV-55): A randomized, open-label, phase III study of mirvetuximab soravtansine versus investigator’s choice of chemotherapy in advanced high-grade epithelial ovarian, primary peritoneal, or fallopian tube cancers with high folate-alpha (FRα) expression

Moore, Kathleen N. ; Van Gorp, Toon ; Wang, Jiuzhou ; Esteves, Brooke ; Zweidler-McKay, Patrick A

Journal of clinical oncology, 2020-05, Vol.38 (15_suppl), p.TPS6103-TPS6103 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
7
Randomized Phase II Study of Bortezomib, Thalidomide, and Dexamethasone With or Without Cyclophosphamide As Induction Therapy in Previously Untreated Multiple Myeloma
Randomized Phase II Study of Bortezomib, Thalidomide, and Dexamethasone With or Without Cyclophosphamide As Induction Therapy in Previously Untreated Multiple Myeloma
Material Type:
Artigo 		Adicionar ao Meu Espaço

Randomized Phase II Study of Bortezomib, Thalidomide, and Dexamethasone With or Without Cyclophosphamide As Induction Therapy in Previously Untreated Multiple Myeloma

LUDWIG, Heinz ; VITERBO, Luisa ; ESTEVES, Graca ; STOPPA, Anne Marie ; ROBINSON, Don ; RICCI, Deborah ; CAKANA, Andrew ; ENNY, Christopher ; HUAIBAO FENG ; DE VELDE, Helgi Van ; HAROUSSEAU, Jean-Luc ; GREIL, Richard ; MASSZI, Tamas ; SPICKA, Ivan ; SHPILBERG, Ofer ; HAJEK, Roman ; DMOSZYNSKA, Anna ; PAIVA, Bruno ; VIDRIALES, María-Belén

Journal of clinical oncology, 2013-01, Vol.31 (2), p.247-255 [Periódico revisado por pares]

Alexandria, VA: American Society of Clinical Oncology

Texto completo disponível

Citações Citado por
8
VEGF inhibitors (VEGFi) activity in liver metastases (mets) regardless of primary cancer type: Meta-analysis and systematic review
VEGF inhibitors (VEGFi) activity in liver metastases (mets) regardless of primary cancer type: Meta-analysis and systematic review
Material Type:
Artigo 		Adicionar ao Meu Espaço

VEGF inhibitors (VEGFi) activity in liver metastases (mets) regardless of primary cancer type: Meta-analysis and systematic review

Pires Da Silva, Ines Esteves Domingues ; Lo, Serigne N. ; Conway, Jordan W. ; Scolyer, Richard A. ; Carlino, Matteo S. ; Menzies, Alexander M. ; Long, Georgina V.

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.3024-3024 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
9
Mirvetuximab soravtansine (MIRV) in patients with platinum-resistant ovarian cancer with high folate receptor alpha (FRα) expression: Characterization of antitumor activity in the SORAYA study
Mirvetuximab soravtansine (MIRV) in patients with platinum-resistant ovarian cancer with high folate receptor alpha (FRα) expression: Characterization of antitumor activity in the SORAYA study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Mirvetuximab soravtansine (MIRV) in patients with platinum-resistant ovarian cancer with high folate receptor alpha (FRα) expression: Characterization of antitumor activity in the SORAYA study

Matulonis, Ursula A. ; Oaknin, Ana ; Pignata, Sandro ; denys, Hannelore ; Colombo, Nicoletta ; Van Gorp, Toon ; Konner, Jason A. ; Romeo, Marga ; Harter, Philipp ; Murphy, Conleth G. ; Wang, Jiuzhou ; Method, Michael W. ; Esteves, Brooke ; Coleman, Robert L. ; Lorusso, Domenica

Journal of clinical oncology, 2022-06, Vol.40 (16_suppl), p.5512-5512 [Periódico revisado por pares]

Texto completo disponível

Citações Citado por
10
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study
Material Type:
Artigo 		Adicionar ao Meu Espaço

Efficacy and Safety of Mirvetuximab Soravtansine in Patients With Platinum-Resistant Ovarian Cancer With High Folate Receptor Alpha Expression: Results From the SORAYA Study

Matulonis, Ursula AA ; Lorusso, Domenica ; Oaknin, Ana ; Pignata, Sandro ; Dean, Andrew ; Denys, Hannelore ; Colombo, Nicoletta ; Van Gorp, Toon ; Konner, Jason AA ; Marin, Margarita Romeo ; Harter, Philipp ; Murphy, Conleth GG ; Wang, Jiuzhou ; Noble, Elizabeth ; Esteves, Brooke ; Method, Michael ; Coleman, Robert LL

JOURNAL OF CLINICAL ONCOLOGY, 2023-05, Vol.41 (13), p.2436-+ [Periódico revisado por pares]

LIPPINCOTT WILLIAMS & WILKINS

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.